Several states wary of $48 billion opioid settlement proposal
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- AMD shares fall amid AI chip sector selloff
- Bloom Energy Corp. (BE) Tops Q3 EPS by 25c, Beats on Revenue; Offers FY26 Guidance
- JetBlue shares fall amid American results, fuel cost concerns
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- Nokia shares fall despite earnings beat on cash flow concerns
Buy Johnson & Johnson (JNJ) on Baby Powder Weakness - Bernstein
October 25, 2019 8:48 AM EDTBernstein analyst Lee Hambright highlights that Johnson & Johnson (NYSE: JNJ) has lost $23 billion in market cap since October 18th, when the company announced a voluntary baby powder recall (33,000 bottles) after the FDA found asbestos at 0.00002% concentration in a sample from a single bottle purchased... More



